Purchase Order 75N92E21P00039

<p>The National Human Genome Research Institute issued a purchase order to Tecan Genomics, Inc. on August 30, 2017, for $5,476.00 under firm fixed-price terms. Performance will take place in North Bethesda, Maryland, with an ultimate completion date of September 30, 2017. No set-aside applied.</p>

<p>The National Human Genome Research Institute issued a purchase order to Tecan U.S., Inc. valued at $3,307.73 on February 26, 2016, for laboratory automation equipment and services.</p> <p>Work is performed at Bethesda, Maryland. The order carries firm fixed pricing with an ultimate completion date of December 21, 2020. No set-aside was applied to this acquisition.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Tecan Genomics, Inc. for $23,019.00 on April 2, 2021, for universal RNA-seq with NuQuant and UDI, Drosophila AnyDeplete. Work is performed at North Bethesda, Maryland. The order is firm fixed-price with no set-aside designation and an ultimate completion date of April 2, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $5,172.00 on August 2, 2017, for completion by September 1, 2017. Place of performance is North Bethesda, Maryland. The order is for firm fixed price commercial items, with no small business set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $6,140.00 on March 15, 2018, with ultimate completion on April 14, 2018. Work is performed at North Bethesda, Maryland. The order is a firm fixed price purchase order with no set-aside applied.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation on July 19, 2018, for $3,038.08, with an ultimate completion date of September 9, 2019. Work is performed in North Bethesda, Maryland. The order is a firm fixed price acquisition for commercial laboratory supplies or reagents supporting genomic research infrastructure. No small business set-aside applies.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. for $11,911.50 on December 16, 2019, with completion by February 29, 2020. The order covers genomic testing services and materials, performed in Bethesda, Maryland. This is a firm fixed price commercial acquisition with no set-aside.</p>

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. valued at $20,097.00 on September 1, 2017, with an ultimate completion date of September 30, 2017. The order is firm fixed price with no set-aside. Place of performance is North Bethesda, Maryland. The source does not specify the items or services procured under this order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $4,452.00 on September 15, 2017, for firm fixed price commercial items. Place of performance is Bethesda, Maryland. The order has an ultimate completion date of December 31, 2017. No set-aside was used.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $18,816.00 on August 31, 2018, with ultimate completion on September 28, 2018. Place of performance is Bethesda, Maryland. The order is priced as firm fixed price with no set-aside used. The source does not specify the items or services procured.</p>